This Is The First Drug-Resistant Fungus Found In The U.S.
A drug-resistant fungus that first emerged in the U.S. only a few years ago has been linked to four deaths, and health officials are on guard about its potential to spread in healthcare facilities throughout the country.
C. auris, a yeast that has sickened people around the globe and caused potentially deadly infections, appears to have arrived in the U.S. a few years ago, according to the first report on C. auris released by the U.S. Centers for Disease Control and Prevention.
Because C. auris cases have cropped up in other countries, the CDC decided to alert all U.S. clinics, labs...
Source: Healthy Living - The Huffington Post - November 5, 2016 Category: Consumer Health News Source Type: news
Disrupting mitochondrial function could improve treatment of fungal infections
By identifying new compounds that selectively block mitochondrial respiration in pathogenic fungi, scientists have identified a potential antifungal mechanism that could enable combination therapy with fluconazole, one of today ' s most commonly prescribed fungal infection treatments. Severe, invasive fungal infections have a mortality rate of 30-50 percent and cause an estimated 1.5 million deaths worldwide annually. Current antifungal therapies are hampered by the increasingly frequent emergence of drug resistance and negative interactions that often preclude combination use. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2016 Category: Science Source Type: news
Disrupting mitochondrial function could improve treatment of fungal infections
(Whitehead Institute for Biomedical Research) By identifying new compounds that selectively block mitochondrial respiration in pathogenic fungi, Whitehead Institute scientists have identified a potential antifungal mechanism that could enable combination therapy with fluconazole, one of today's most commonly prescribed fungal infection treatments. Severe, invasive fungal infections have a mortality rate of 30-50 percent and cause an estimated 1.5 million deaths worldwide annually. Current antifungal therapies are hampered by the increasingly frequent emergence of drug resistance and negative interactions that often preclud...
Source: EurekAlert! - Medicine and Health - August 11, 2016 Category: Global & Universal Source Type: news
Diflucan (Fluconazole) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 19, 2016 Category: Drugs & Pharmacology Source Type: news
Candida auris: laboratory investigation, management and infection prevention and control
This document provides guidance about sending Candida spp isolates for laboratory testing, treatment and decolonisation of patients and screening in hospitals, and infection prevention and control measures. Candida auris is a pathogenic yeast species that has been reported to cause bloodstream infections, wound infections, and otitis. It has also been cultured from urine and the respiratory tract. Unlike other pathogenic yeast species, C. auris appears to have a propensity for transmission between hospital patients. It is commonly resistant to the first-line antifungal, fluconazole and can develop resistance to other class...
Source: Current Awareness Service for Health (CASH) - July 13, 2016 Category: Consumer Health News Source Type: news
Fluconazole Injection (Fluconazole Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 10, 2016 Category: Drugs & Pharmacology Source Type: news
F.D.A. Urges Caution on Yeast Infection Drug During Pregnancy
The agency had previously warned that high doses of the drug, fluconazole, might be linked to birth defects. A new study suggests dangers at lower doses. (Source: NYT Health)
Source: NYT Health - April 27, 2016 Category: Consumer Health News Authors: CATHERINE SAINT LOUIS Tags: Pregnancy and Childbirth Drugs (Pharmaceuticals) Yeast Infections Miscarriages Food and Drug Administration fluconazole Source Type: news
Yeast Infection Drug May Raise Miscarriage Risk
Agency recommends alternatives to fluconazole for mothers-to-be until its review is complete (Source: WebMD Health)
Source: WebMD Health - April 26, 2016 Category: Consumer Health News Source Type: news
FDA: Yeast Infection Drug Might Increase Miscarriage Risk (FREE)
By Kristin J. Kelley
Edited by Lorenzo Di Francesco, MD, FACP, FHM
Clinicians should exercise caution when prescribing the oral antifungal fluconazole (Diflucan and generics) to pregnant women, the FDA warned on Tuesday, because the drug might pose increased … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 26, 2016 Category: Primary Care Source Type: news
Yeast infection drug may raise miscarriage risk, FDA warns
HealthDay News Doctors should use caution when prescribing the antifungal drug fluconazole during pregnancy because it may raise the risk of miscarriage, the FDA warns. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 26, 2016 Category: Consumer Health News Source Type: news
Drug for Yeast Infections May Raise Miscarriage Risk, FDA Warns
Agency recommends alternatives to fluconazole for mothers-to-be until its review is complete
Source: HealthDay
Related MedlinePlus Pages: Miscarriage, Pregnancy, Yeast Infections (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 26, 2016 Category: Consumer Health News Source Type: news
Low-Dose Fluconazole in Pregnancy Worries FDALow-Dose Fluconazole in Pregnancy Worries FDA
Clinicians should exercise caution prescribing oral fluconazole to treat yeast infections in pregnant women, given new evidence that even low doses may cause miscarriages, the agency said. News Alerts (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 26, 2016 Category: Primary Care Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news
FDA Probes Fluconazole Risks in Pregnancy
(MedPage Today) -- "Cautious prescribing" urged until safety review is complete (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 26, 2016 Category: American Health Source Type: news
Drug for Yeast Infections May Raise Miscarriage Risk, FDA Warns
TUESDAY, April 26, 2016 -- Doctors should use caution when prescribing the antifungal drug fluconazole during pregnancy because it may raise the risk of miscarriage, the U.S. Food and Drug Administration warns.
Fluconazole (brand name Diflucan) is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2016 Category: Journals (General) Source Type: news
FDA Drug Safety Communication: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy
The U.S. Food and Drug Administration (FDA) is evaluating the results of a Danish study1 that concludes there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) for yeast infections. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 26, 2016 Category: Drugs & Pharmacology Source Type: news
